SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036925
Filing Date
2020-11-13
Accepted
2020-11-13 16:09:36
Documents
46
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_adialpharma.htm 10-Q 456425
2 CERTIFICATION f10q0920ex31-1_adial.htm EX-31.1 11035
3 CERTIFICATION f10q0920ex31-2_adial.htm EX-31.2 11048
4 CERTIFICATION f10q0920ex32-1_adial.htm EX-32.1 3940
5 CERTIFICATION f10q0920ex32-2_adial.htm EX-32.2 3866
6 GRAPHIC image_001.jpg GRAPHIC 91984
  Complete submission text file 0001213900-20-036925.txt   2784267

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adil-20200930.xml EX-101.INS 371062
8 XBRL SCHEMA FILE adil-20200930.xsd EX-101.SCH 43795
9 XBRL CALCULATION FILE adil-20200930_cal.xml EX-101.CAL 28786
10 XBRL DEFINITION FILE adil-20200930_def.xml EX-101.DEF 141583
11 XBRL LABEL FILE adil-20200930_lab.xml EX-101.LAB 277338
12 XBRL PRESENTATION FILE adil-20200930_pre.xml EX-101.PRE 202184
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 201311566
SIC: 2834 Pharmaceutical Preparations